Literature DB >> 33652663

A Typical Case Presentation with Spontaneous Visual Recovery in Patient Diagnosed with Leber Hereditary Optic Neuropathy due to Rare Point Mutation in MT-ND4 Gene (m.11253T>C) and Literature Review.

Rasa Liutkeviciene1,2, Agne Sidaraite1, Lina Kuliaviene1, Brigita Glebauskiene1, Neringa Jurkute3, Lina Aluzaite-Baranauskiene1, Arvydas Gelzinis1, Reda Zemaitiene1.   

Abstract

Leber hereditary optic neuropathy (LHON) is one of the most common inherited mitochondrial optic neuropathies, caused by mitochondrial DNA (mtDNA) mutations. Three most common mutations, namely m.11778G>A, m.14484T>G and m.3460G>A, account for the majority of LHON cases. These mutations lead to mitochondrial respiratory chain complex I damage. Typically, LHON presents at the 15-35 years of age with male predominance. LHON is associated with severe, subacute, painless bilateral vision loss and account for one of the most common causes of legal blindness in young individuals. Spontaneous visual acuity recovery is rare and has been reported in patients harbouring m.14484T>C mutation. Up to date LHON treatment is limited. Idebenone has been approved by European Medicines Agency (EMA) to treat LHON. However better understanding of disease mechanisms and ongoing treatment trials are promising and brings hope for patients. In this article we report on a patient diagnosed with LHON harbouring rare m.11253T>C mutation in MT-ND4 gene, who experienced spontaneous visual recovery. In addition, we summarise clinical presentation, diagnostic features, and treatment.

Entities:  

Keywords:  LHON; Leber hereditary optic neuropathy; aetiology; diagnosis; treatment

Year:  2021        PMID: 33652663      PMCID: PMC7996816          DOI: 10.3390/medicina57030202

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  64 in total

1.  Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland.

Authors:  Anu Puomila; Petra Hämäläinen; Sanna Kivioja; Marja-Liisa Savontaus; Satu Koivumäki; Kirsi Huoponen; Eeva Nikoskelainen
Journal:  Eur J Hum Genet       Date:  2007-04-04       Impact factor: 4.246

2.  Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber's hereditary optic neuropathy.

Authors:  Y Mashima; K Yamada; M Wakakura; K Kigasawa; J Kudoh; N Shimizu; Y Oguchi
Journal:  Curr Eye Res       Date:  1998-04       Impact factor: 2.424

3.  Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite.

Authors:  Nancy J Newman; Valerie Biousse; Robert David; M Tariq Bhatti; Steven R Hamilton; Bradley K Farris; Robert L Lesser; Steven A Newman; Roger E Turbin; Kuankuan Chen; Robert P Keaney
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

4.  Seven-Year Follow-up of Gene Therapy for Leber's Hereditary Optic Neuropathy.

Authors:  Jiajia Yuan; Yong Zhang; Hongli Liu; Dan Wang; Yangyang Du; Zhen Tian; Xin Li; Shuo Yang; Han Pei; Xing Wan; Su Xiao; Lin Song; Xiao Xiao; Jian Sun; Zhitao Wang; Bin Li
Journal:  Ophthalmology       Date:  2020-02-25       Impact factor: 12.079

5.  Clinical and Optic Disc Characteristics of Patients Showing Visual Recovery in Leber Hereditary Optic Neuropathy.

Authors:  Yeji Moon; Ungsoo S Kim; Jinu Han; Hyosook Ahn; Hyun Taek Lim
Journal:  J Neuroophthalmol       Date:  2020-03       Impact factor: 3.042

Review 6.  Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits.

Authors:  Vanna Geromel; Niklas Darin; Dominique Chrétien; Paule Bénit; Pascale DeLonlay; Agnès Rötig; Arnold Munnich; Pierre Rustin
Journal:  Mol Genet Metab       Date:  2002 Sep-Oct       Impact factor: 4.797

7.  Posterior reversible encephalopathy syndrome in a leber hereditary optic neuropathy patient with mitochondrial DNA 11778G>A point mutation.

Authors:  Yuwei Da; Xuxiang Zhang; Fang Li; Xiaoping Yang; Xinqing Zhang; Jianping Jia
Journal:  J Neuroophthalmol       Date:  2013-09       Impact factor: 3.042

8.  Homoplasmy, heteroplasmy, and mitochondrial dystonia.

Authors:  R McFarland; P F Chinnery; E L Blakely; A M Schaefer; A A M Morris; S M Foster; H A L Tuppen; V Ramesh; P J Dorman; D M Turnbull; R W Taylor
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

9.  Clinical, Genetic, and Radiological Features of Extrapyramidal Movement Disorders in Mitochondrial Disease.

Authors:  Mika H Martikainen; Yi Shiau Ng; Gráinne S Gorman; Charlotte L Alston; Emma L Blakely; Andrew M Schaefer; Patrick F Chinnery; David J Burn; Robert W Taylor; Robert McFarland; Doug M Turnbull
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

10.  International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy.

Authors:  Valerio Carelli; Michele Carbonelli; Irenaeus F de Coo; Aki Kawasaki; Thomas Klopstock; Wolf A Lagrèze; Chiara La Morgia; Nancy J Newman; Christophe Orssaud; Jan Willem R Pott; Alfredo A Sadun; Judith van Everdingen; Catherine Vignal-Clermont; Marcela Votruba; Patrick Yu-Wai-Man; Piero Barboni
Journal:  J Neuroophthalmol       Date:  2017-12       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.